查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1953387

蛋白質結合分析市場 - 全球產業規模、佔有率、趨勢、機會及預測（按技術、產品/服務、最終用戶、地區和競爭格局分類，2021-2031年）

Protein Binding Assays Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology, By Product and Services, By End-Users, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球蛋白質結合分析市場預計將從 2025 年的 5.8065 億美元成長到 2031 年的 10.6336 億美元，複合年成長率為 10.61%。

這些檢測方法是專門的分析程序，用於量化藥物分子與血漿蛋白的可逆結合，這是確定具有治療活性的遊離藥物比例的關鍵步驟。該市場的成長主要源於藥物發現早期階段對生物利用度和毒性特徵的必要評估，這項策略旨在降低後期研發階段的失敗率。此外，對藥物創新的巨額投資也進一步推動了這一成長。根據歐洲製藥工業協會聯合會（EFPIA）預測，到2024年，歐洲以研發為基礎的製藥業預計將在研發方面投入約550億歐元，這筆巨額資本投資也保證了對這些臨床前服務的需求。

市場概覽
預測期 2027-2031
市場規模：2025年 5.8065億美元
市場規模：2031年 1,063,360,000 美元
複合年成長率：2026-2031年 10.61%
成長最快的細分市場 平衡透析
最大的市場 北美洲

儘管市場成長勢頭強勁，但由於先進的平衡透析和表面等離子共振技術的複雜性和高成本，該市場仍面臨顯著的挑戰。精確測量蛋白質交互作用需要專用設備和高技能人員，這造成了財務和營運負擔，可能阻礙技術的廣泛應用。對於小規模的生技公司而言，這個問題尤其突出，因為這些先進檢測技術的固定成本可能超過其可用資源，並阻礙其融入標準工作流程。

市場促進因素

製藥和生物技術領域研發投入的不斷成長是市場擴張的主要催化劑，直接推動了候選藥物研發失敗率，越來越多的資金被投入ADME（吸收、分佈、代謝和排泄）分析中，該分析用於評估化合物與血漿蛋白（如白蛋白和α1-酸性Glico）的相互作用。這筆巨額資金投入使實驗室能夠獲得必要的試劑並檢驗通訊協定。例如，美國藥品研究與製造商協會（PhRMA）在2024年9月發布的一項調查報告顯示，其成員公司將在2023年投入創紀錄的1035億美元用於研發，這凸顯了生物分析研究領域獲得的巨額資金。

此外，慢性病和感染疾病的日益增多迫使製藥業加快藥物研發步伐，導致所需的結合研究數量激增。美國癌症協會預測，到2024年1月，美國新增癌症病例將首次超過200萬例，顯示患者對快速創新治療方法和精準給藥的需求日益成長。這種壓力推動了檢測服務提供者對檢測處理容量要求不斷提高，美國食品藥物管理局（FDA）2024年的報告也印證了這個趨勢。報告指出，去年有55種新型療法核准，這反映了這些檢測流程的持續成功和重要性。

市場挑戰

全球蛋白質結合分析市場面臨許多挑戰，例如平衡透析和表面等離子共振等先進技術的技術複雜性和高昂的營運成本。實施這些先進的分析方法需要對設備進行大量資本投入，並招募高技能人員以確保數據解讀的準確性。對於中小型生物技術公司（創新流程中的關鍵環節）而言，這些固定成本往往超出其可用資源，限制了它們內部建立重要檢測能力，從而有效地抑制了市場規模的成長和滲透率的提高。

中小規模市場參與企業流動性有限，限制了它們投資資本密集型設備的能力，這加劇了上述挑戰。根據英國生物產業協會（BIA）2024年的數據，英國生技產業已資金籌措了35億英鎊，但首次股票公開發行（IPO）卻連續第二年完全停滯。資本結構失衡，資金集中在少數企業手中，且缺乏公開市場退出管道，這顯著降低了更廣泛客戶群的購買力；此外，蛋白質偶聯技術的高成本也對資金緊張的開發商構成了重大障礙。

市場趨勢

生物製劑和標靶蛋白分解劑結合分析方法的擴展正在從根本上改變市場格局，因為與傳統小分子藥物相比，這些複雜的藥物需要高度專業的檢測通訊協定。研發人員越來越關注大分子相互作用的評估，包括胜肽和寡核苷酸，這需要複雜的檢測方法才能準確評估結合動力學和親和性。藥明康德2024年3月發布的報告清晰地展現了這種結構性轉變，該公司TIDES業務（肽和寡核苷酸）的收入同比成長64.4%，反映了行業正迅速向這些複雜的治療領域轉型。

隨著技術多元化的發展，將結合研究外包給受託研究機構(CRO) 的趨勢日益明顯，以此來規避自行建構先進檢測平台的高昂資本投入。隨著蛋白質交互作用的測量變得日益複雜，製藥公司正利用 CRO 的專業基礎設施來維持高通量檢測能力，而無需承擔購買專用設備的固定成本。這種對外部夥伴關係模式的依賴正在推動服務業的顯著成長。 Icon PLC 截至 2024 年 2 月的會計年度報告顯示，其年收入達 81.2 億美元（年增 4.9%），這主要得益於對外包研發服務的持續需求。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章：全球蛋白質結合分析市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 透過技術（平衡透析、親和性和電泳、超過濾、超速離心、表面等離子體共振等）
    • 依產品/服務分類（儀器、試劑盒/試劑、服務）
    • 按最終用戶（製藥/生物技術公司、契約製造組織 (CRO) 及其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美蛋白質結合測定市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲蛋白質結合分析市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區蛋白質結合分析市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲蛋白質結合測定市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

10. 南美洲蛋白質結合測定市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球蛋白質結合分析市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Sovicell
  • Cyprotex（Evotec AG）
  • Bioduro. LLC
  • GE HealthCare Technologies Inc.
  • Beckman Coulter, Inc.
  • Sartorius AG
  • Bio-Rad Laboratories, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23975

The Global Protein Binding Assays Market is projected to expand from USD 580.65 Million in 2025 to USD 1063.36 Million by 2031, reflecting a compound annual growth rate of 10.61%. These assays are specialized analytical procedures designed to quantify the reversible association between drug molecules and plasma proteins, a critical step in determining the free fraction of a drug available for therapeutic action. The market is primarily driven by the essential need to evaluate bioavailability and toxicity profiles during the early stages of drug discovery, a strategy aimed at reducing attrition rates in later development phases. This growth is further supported by significant financial investments in pharmaceutical innovation; according to the European Federation of Pharmaceutical Industries and Associations, the research-based pharmaceutical industry invested an estimated €55,000 million in R&D in Europe during 2024, highlighting the substantial capital ensuring the demand for these preclinical services.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 580.65 Million
Market Size 2031USD 1063.36 Million
CAGR 2026-203110.61%
Fastest Growing SegmentEquilibrium Dialysis
Largest MarketNorth America

Despite this strong growth trajectory, the market faces a notable challenge regarding the technical complexity and high costs linked to advanced equilibrium dialysis and surface plasmon resonance technologies. The necessity for specialized equipment and highly skilled personnel to accurately measure protein interactions creates financial and operational burdens that can hinder broader adoption. This is particularly problematic for smaller biotechnology firms, where the high fixed costs of these sophisticated testing capabilities may exceed available resources, thereby impeding their integration into standard workflows.

Market Driver

The escalation of R&D investments within the pharmaceutical and biotechnology sectors acts as a primary catalyst for market expansion, directly facilitating the rigorous preclinical evaluations necessary for new drug candidates. As developers aim to minimize attrition, financial resources are increasingly directed toward ADME profiling to assess compound interactions with plasma proteins like albumin and alpha-1-acid glycoprotein. This significant capital commitment ensures laboratories can secure necessary reagents and validate protocols; for instance, the Pharmaceutical Research and Manufacturers of America reported in their September 2024 survey that member companies invested a record $103.5 billion in R&D during 2023, underscoring the massive funding available for these bioanalytical investigations.

Furthermore, the rising prevalence of chronic and infectious diseases forces the industry to accelerate drug discovery efforts, thereby increasing the volume of required binding studies. The American Cancer Society projected in January 2024 that new cancer cases in the United States would exceed 2 million for the first time, signaling a growing patient need that necessitates rapid therapeutic innovation and precise dosing determination. This pressure results in higher throughput requirements for assay providers, a trend validated by the U.S. Food and Drug Administration's 2024 report, which noted the approval of 55 novel therapeutics in the previous year, reflecting the sustained output and importance of these testing workflows.

Market Challenge

The Global Protein Binding Assays Market faces significant barriers due to the technical complexity and substantial operational costs associated with advanced technologies such as equilibrium dialysis and surface plasmon resonance. Implementing these sophisticated analytical methods requires major capital expenditure on instrumentation and the hiring of highly skilled personnel to ensure accurate data interpretation. For smaller biotechnology firms, which represent a crucial segment of the innovation pipeline, these fixed costs often surpass available resources, restricting their ability to internalize critical testing capabilities and effectively capping the market's volume growth and adoption rates.

This challenge is further exacerbated by the restricted liquidity available to smaller market participants, limiting their capacity to invest in capital-intensive equipment. According to the BioIndustry Association in 2024, while the UK biotech sector raised £3.5 billion in financing, there was a complete dormancy of initial public offerings (IPOs) for the second consecutive year. This capitalization imbalance, where funding is concentrated among fewer players and public exit routes are closed, severely reduces the purchasing power of the broader client base, making the high cost of protein binding technologies a primary friction point for financially constrained developers.

Market Trends

The market landscape is being fundamentally altered by the expansion of binding assays for biologics and targeted protein degraders, as these complex modalities demand highly specialized testing protocols compared to traditional small molecules. Developers are increasingly focusing on evaluating large molecule interactions, such as those involving peptides and oligonucleotides, which requires advanced assay formats to accurately characterize binding kinetics and affinity. This structural shift is highlighted by WuXi AppTec's March 2024 report, which noted that revenue from their TIDES business (peptides and oligonucleotides) grew by 64.4% year-over-year, reflecting the industry's rapid pivot toward these complex therapeutic areas.

Concurrent with this technical diversification is a growing trend of outsourcing binding studies to contract research organizations (CROs) as a strategy to bypass the high capital barriers of internalizing advanced assay platforms. As the complexity of measuring protein interactions increases, pharmaceutical companies are leveraging the specialized infrastructure of CROs to maintain high-throughput capabilities without the fixed costs of specialized instrumentation. This reliance on external partnership models is driving significant growth in the service sector, evidenced by Icon PLC's February 2024 report, which announced full-year revenue of $8.12 billion, a 4.9% increase over the prior year fueled by sustained demand for externalized development services.

Key Market Players

  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Sovicell
  • Cyprotex (Evotec A.G.)
  • Bioduro. LLC
  • GE HealthCare Technologies Inc.
  • Beckman Coulter, Inc.
  • Sartorius AG
  • Bio-Rad Laboratories, Inc.

Report Scope

In this report, the Global Protein Binding Assays Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Protein Binding Assays Market, By Technology

  • Equilibrium Dialysis
  • Affinity Electrophoresis
  • Ultrafiltration
  • Ultracentrifugation
  • Surface Plasmon Resonance
  • Others

Protein Binding Assays Market, By Product and Services

  • Instrument
  • Kits and Reagents
  • Services

Protein Binding Assays Market, By End-Users

  • Pharmaceutical and Biotechnology Companies
  • Contract Manufacturing Organizations (CROs)
  • Others

Protein Binding Assays Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Protein Binding Assays Market.

Available Customizations:

Global Protein Binding Assays Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Protein Binding Assays Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technology (Equilibrium Dialysis, Affinity Electrophoresis, Ultrafiltration, Ultracentrifugation, Surface Plasmon Resonance, Others)
    • 5.2.2. By Product and Services (Instrument, Kits and Reagents, Services)
    • 5.2.3. By End-Users (Pharmaceutical and Biotechnology Companies, Contract Manufacturing Organizations (CROs), Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Protein Binding Assays Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology
    • 6.2.2. By Product and Services
    • 6.2.3. By End-Users
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Protein Binding Assays Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technology
        • 6.3.1.2.2. By Product and Services
        • 6.3.1.2.3. By End-Users
    • 6.3.2. Canada Protein Binding Assays Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technology
        • 6.3.2.2.2. By Product and Services
        • 6.3.2.2.3. By End-Users
    • 6.3.3. Mexico Protein Binding Assays Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technology
        • 6.3.3.2.2. By Product and Services
        • 6.3.3.2.3. By End-Users

7. Europe Protein Binding Assays Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By Product and Services
    • 7.2.3. By End-Users
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Protein Binding Assays Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technology
        • 7.3.1.2.2. By Product and Services
        • 7.3.1.2.3. By End-Users
    • 7.3.2. France Protein Binding Assays Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technology
        • 7.3.2.2.2. By Product and Services
        • 7.3.2.2.3. By End-Users
    • 7.3.3. United Kingdom Protein Binding Assays Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technology
        • 7.3.3.2.2. By Product and Services
        • 7.3.3.2.3. By End-Users
    • 7.3.4. Italy Protein Binding Assays Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technology
        • 7.3.4.2.2. By Product and Services
        • 7.3.4.2.3. By End-Users
    • 7.3.5. Spain Protein Binding Assays Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technology
        • 7.3.5.2.2. By Product and Services
        • 7.3.5.2.3. By End-Users

8. Asia Pacific Protein Binding Assays Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Product and Services
    • 8.2.3. By End-Users
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Protein Binding Assays Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technology
        • 8.3.1.2.2. By Product and Services
        • 8.3.1.2.3. By End-Users
    • 8.3.2. India Protein Binding Assays Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technology
        • 8.3.2.2.2. By Product and Services
        • 8.3.2.2.3. By End-Users
    • 8.3.3. Japan Protein Binding Assays Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technology
        • 8.3.3.2.2. By Product and Services
        • 8.3.3.2.3. By End-Users
    • 8.3.4. South Korea Protein Binding Assays Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technology
        • 8.3.4.2.2. By Product and Services
        • 8.3.4.2.3. By End-Users
    • 8.3.5. Australia Protein Binding Assays Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technology
        • 8.3.5.2.2. By Product and Services
        • 8.3.5.2.3. By End-Users

9. Middle East & Africa Protein Binding Assays Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Product and Services
    • 9.2.3. By End-Users
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Protein Binding Assays Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technology
        • 9.3.1.2.2. By Product and Services
        • 9.3.1.2.3. By End-Users
    • 9.3.2. UAE Protein Binding Assays Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technology
        • 9.3.2.2.2. By Product and Services
        • 9.3.2.2.3. By End-Users
    • 9.3.3. South Africa Protein Binding Assays Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technology
        • 9.3.3.2.2. By Product and Services
        • 9.3.3.2.3. By End-Users

10. South America Protein Binding Assays Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technology
    • 10.2.2. By Product and Services
    • 10.2.3. By End-Users
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Protein Binding Assays Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technology
        • 10.3.1.2.2. By Product and Services
        • 10.3.1.2.3. By End-Users
    • 10.3.2. Colombia Protein Binding Assays Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technology
        • 10.3.2.2.2. By Product and Services
        • 10.3.2.2.3. By End-Users
    • 10.3.3. Argentina Protein Binding Assays Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technology
        • 10.3.3.2.2. By Product and Services
        • 10.3.3.2.3. By End-Users

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Protein Binding Assays Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Merck KGaA
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Thermo Fisher Scientific Inc.
  • 15.3. Sovicell
  • 15.4. Cyprotex (Evotec A.G.)
  • 15.5. Bioduro. LLC
  • 15.6. GE HealthCare Technologies Inc.
  • 15.7. Beckman Coulter, Inc.
  • 15.8. Sartorius AG
  • 15.9. Bio-Rad Laboratories, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer